CGA: Glucose Oxidase, Glucose

Product code CGA, “Glucose Oxidase, Glucose” in FDA's classification database, is a Class II device type under 21 CFR 862.1345 (glucose test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 401 clearances under CGA, 52 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
CGA
Regulation
21 CFR 862.1345
Class
II
Panel
Clinical Chemistry
Clearances
401
Most recent
May 1, 2026
Median review, last 2 years
266 days
Third-party review
Eligible
Implant
No

What it covers

A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

The identification in 21 CFR 862.1345, glucose test system. FDA gives CGA no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K252488ABL90 FLEX PLUS SystemRadiometer Medicals ApsMay 1, 2026Traditional
K210933YSI 2900C Biochemistry AnalyzerYsi, Inc.Sep 30, 2024Traditional
K220328EasyStat 300Medica CorporationJul 26, 2024Traditional
K223179Cholestech LDX ™ SystemAlere San Diego, Inc.Sep 20, 2023Dual Track
K223755i-STAT G cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.Sep 11, 2023Traditional
K223710i-STAT CG8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.Jul 28, 2023Traditional
K223090GEM Premier ChemSTATInstrumentation Laboratory COJan 27, 2023Special
K203549Nova Primary Glucose Analyzer SystemNova Biomedical CorporationOct 18, 2022Traditional
K210958i-STAT CHEM8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.Aug 13, 2021Traditional
K200349Stat Profile Prime Plus Analyzer SystemNova Biomedical CorporationMar 13, 2020Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 401 with a free account)

Clearances by year

52 CGA 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)1266
202421092
20234249
20221683
20211135
20202218
2019244
20182156
20172213
20164157
20154150
20145265
20133441
201210123
20119217

Who submits

29 applicants cleared a CGA device since 2011. 65% of the clearances went to applicants in United States, then Taiwan (23%), South Korea (6%) and Denmark (2%). By type: Traditional 69%, Special 29% and Dual Track 2%.

ApplicantClearances since 2011
Apex BioTechnology Corp.7
Abbott Point of Care, Inc.6
Instrumentation Laboratory CO4
I-Sens, Inc.3
Nova Biomedical Corporation3
ACON Laboratories, Inc.2
Arkray Factory, Inc.2
Bestgen Biotech Corp.2

How FDA classifies it

Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

From 21 CFR 862.1345. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 862.1345 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent CGA clearances declared.

Ask about CGA

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about CGA

What is FDA product code CGA?

Product code CGA, “Glucose Oxidase, Glucose” in FDA's classification database, is a Class II device type under 21 CFR 862.1345 (glucose test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 401 clearances under CGA, 52 of them since 2011.

How many 510(k) clearances are there under CGA?

FDA’s 510(k) database listed 401 clearances under CGA as of Oct 29, 2026, 52 of them decided since 2011; the most recent decision was May 1, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a CGA 510(k)?

For the 1 CGA clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 266 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most CGA clearances?

Since 2011: Apex BioTechnology Corp. (7), Abbott Point of Care, Inc. (6), Instrumentation Laboratory CO (4), I-Sens, Inc. (3) and Nova Biomedical Corporation (3). 29 applicants have cleared a CGA device in that time.

Sources

  1. FDA product classification: CGA · Product Classification database
  2. 21 CFR 862.1345: Glucose test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for CGA · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow CGAGet an email when FDA clears, recalls or publishes guidance for CGA devices.

Know what FDA already cleared.